Optimizing one-dose and two-dose cholera vaccine allocation in outbreak settings: A modeling study
Fig 6
Reductions in metrics of disease burden from the vaccination campaigns over three years.
Percentage of total infections (left), symptomatic infections (center), and deaths (right) averted over three years for A–C: Chad, D–F: Maela, and G–I: Haiti. We considered enough vaccine to cover 10–100% of the population with a single dose.